|
|
Volumn 163, Issue 7, 2006, Pages 1123-1125
|
|
STAR*D: The results begin to roll in
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
BUSPIRONE;
CITALOPRAM;
DOPAMINE;
MIRTAZAPINE;
NORADRENALIN;
NORTRIPTYLINE;
SEROTONIN;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
VENLAFAXINE;
CLINICAL RESEARCH;
COGNITIVE THERAPY;
DEPRESSION;
DISEASE COURSE;
DISEASE EXACERBATION;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG INDUSTRY;
EDITORIAL;
EVIDENCE BASED MEDICINE;
HUMAN;
INDIVIDUALIZATION;
MAJOR DEPRESSION;
PRIORITY JOURNAL;
REMISSION;
TREATMENT INDICATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CROSSOVER PROCEDURE;
DRUG COMBINATION;
METHODOLOGY;
NOTE;
PSYCHOLOGICAL ASPECT;
RANDOMIZED CONTROLLED TRIAL;
STANDARD;
STATISTICS;
TREATMENT OUTCOME;
ANTIDEPRESSIVE AGENTS;
CROSS-OVER STUDIES;
DEPRESSIVE DISORDER;
DRUG THERAPY, COMBINATION;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
TREATMENT OUTCOME;
|
|
EID: 33746877922
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.163.7.1123 Document Type: Editorial |
|
Times cited : (20)
|
|
References (9)
|
